期刊文献+

青霉素Etest法评价肺炎链球菌苯唑西林的纸片筛选试验 被引量:2

Evaluation of oxacillin disk test for screening Streptococcus pneumoniae by penicillin Etest method
下载PDF
导出
摘要 目的青霉素Etest法评价肺炎链球菌苯唑西林的纸片筛选试验。方法对临床分离的96株肺炎链球菌非脑膜炎株,用Etest作为测定青霉素敏感性的标准方法,评价苯唑西林的纸片筛选试验的灵敏度和特异性。结果 96株肺炎链球菌非脑膜炎株,用Etest测定青霉素敏感株(PSSP)为96.9%(93/96),青霉素中度敏感株(PISP)为3.1%(3/96),未发现青霉素耐药株(PRSP)。苯唑西林纸片法初筛出16株PSSP,灵敏度为17.2%,特异性为100.0%。苯唑西林纸片法与Etest方法比较,差异有统计学意义(χ2=77,P<0.01)。结论苯唑西林纸片法作为肺炎链球菌非脑膜炎株青霉素注射剂敏感性的初筛方法灵敏度低,大部分肺炎链球菌必须用Etest等MIC方法检测。 Objective To evaluate the oxacillin disk screening test for screening Streptococcus pneumoniae by the penicillin Etest method.Methods 96 clinically isolated non-meningitis strains of Streptococcus pneumoniae were collected.The sensitivity and spe-cificity of the oxacillin disc screening test was evaluated by the penicillin Etest method as a standard method for detecting the peni-cillin susceptibility.Results Among 96 non-meningitis strains of Streptococcus pneumoniae,the penicillin-susceptible Streptococcus pneumoniae(PSSP)strains detected by the penicillin Etest method accounted for 96.9%(93/96),the penicillin intermediate Strep-tococcus pneumoniae(PISP)strains accounted for 3.1%(3/96)and no penicillin resistant Streptococcus pneumoniae(PRSP)strain was found.But 16 PSSP strains were detected by the oxacillin disc screening test with the sensitivity of 17.2% and the specificity of 100.0%,respectively.The difference between the oxacillin disc screening test and the penicillin Etest method was statistically sig-nificant(χ2 =77,P 〈0.01 ).Conclusion The oxacillin disc screening test has the low sensitivity for preliminarily screening non-meningitis strains of Streptococcus pneumoniae.Most of Streptococcus pneumoniae must be detected by the minimum inhibitory concentration(MIC)methods such as the penicillin Etest method.
出处 《国际检验医学杂志》 CAS 2014年第16期2210-2211,共2页 International Journal of Laboratory Medicine
基金 贵州省卫生厅科学技术基金(gzwkj2012-1-106) 贵州省科技计划课题(黔科合LS字[2012]030号)
关键词 肺炎链球菌 脑膜炎 苯唑西林 streptococcus pneumoniae meningitis oxacillin
  • 相关文献

参考文献6

  • 1Clinical and Laboratory Standards Institute. M100-S18 Perform- ance Standards for Antimicrobial Susceptibility Testing t eigh- teenth informational supplement[S]. Wayne, PA, USA: CLSI, 2008.
  • 2Clinical and Laboratory Standards Institute. M100-S22 Perform- ante Standards for Antimicrobial Susceptibility Testing: Twenty- second informational supplement [S]. Wayne, PA, USA: CLSI, 2012.
  • 3Centers for disease control and prevention(CDC). Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae- United States,2006-2007[J]. MMWR Morb Mortal Wkly Rep, 2008,57(50) :1353 -1355.
  • 4Mera RM, Miller LA, Amrine-Madsen H, et al. Impact of new Clinical Laboratory Standards Institute Streptococcus pneumoniae penicillin susceptibility testing breakpoints on reported resistance changes over time[J]. Microb Drug Resist, 2011,17 (1) : 47-52.
  • 5李建平,叶青,沈月芳,楼杨方,陈学军,华春珍,尚世强,陈志敏.2009~2010年浙江大学儿童医院肺炎链球菌耐药性和血清分型[J].中国药学杂志,2012,47(10):792-795. 被引量:6
  • 6华春珍,李建平,俞惠民,尚世强,陈志敏,徐立群.应用CLSI新的折点值标准判读儿童分离的肺炎链球菌非脑膜炎株的耐药性[J].中国抗生素杂志,2012,37(2):137-140. 被引量:5

二级参考文献23

  • 1姚开虎,陆权,邓力,俞桑洁,张泓,邓秋莲,佟月娟,高薇,袁林,沈叙庄,杨永弘.2000-2002年三家儿童医院分离的肺炎链球菌血清型分布及其对β内酰胺类抗生素敏感性的变化[J].中华儿科杂志,2006,44(12):928-932. 被引量:15
  • 2Centers for disease control and prevention(CDC). Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae--United States, 2006-2007[J]. MMWR Morb Mortal Wkly Rep, 2008, 19, 57(50): 1353-1355.
  • 3Dogan O, Gulmez D, Hasgelik G. Effect of new breakpoints proposed by clinical and laboratory standards institute in 2008 for evaluating penicillin resistance of Streptococcus pneumoniae in a Turkish University Hospital[J]. Microb Drug Resist, 2010, 16 (1): 39-41.
  • 4Perez-Trallero E, Martin-Herrero J E, Mazen A, et al. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years(1996-1997 to 2006-2007) [J]. Antimicrob Agents Chemother, 2010, 54(7): 2953-1959.
  • 5MAHONEY R T, KRATI'IGER A, CLEMENS J D, et al. The in- troduction of new vaccines into developing countries IV: Global Access Strategies [ J ]. Vaccine, 2007,25 ( 20 ) :4003 -4011.
  • 6DONGW JIDD BAOYY etal.Aanalysis of bacterial resist- ance to antibiotics in our hospital during1996to1999.中国药学杂志,2001,36(1):61-63.
  • 7Centers for Disease Control and Prevention (CDC). Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae- United States,2006-2007 [ J]. Morb Mortal Wkly Rep, 2008, 57 (50) : 1353-1355.
  • 8PEREZ-TRALLERO E, MARTIN-HERRERO J E, MAZON A, et al. Antimicrohial resistance among respiratory pathogens in Spain : latest data and changes over 11 years (1996-1997 to 2006-2007) [ J ]. Antimicrob Agents Chemother, 2010,54 (7) :2953-2959.
  • 9WANGF ZHUDM HUFP etal.CHINET2009surveillance of bacterial resistance in china.国感染与化疗杂志,2010,10(5):325-334.
  • 10RODGERS G L, ARGUEDAS A, COHEN R,et al. Global sero- type distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines[J]. Vaccine,2009,27(29) :3802-3810.

共引文献8

同被引文献9

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部